@bythewell - There are financial arguments for both sides. There's a reason that waiting lists have to be that long. The only reason they are shorter in places without universal health care is that those places simply don't have as many people able to get surgery. So it's only a question of a handful of people having to wait in one scenario, versus a lot of people dying because they can't afford the surgery at all in the second.
And the pharmaceutical companies might not be able to make the record profits they make now, but considering how many of them exist and survive in Europe, I don't think that will actually be a long term problem for the consumer.